Companies: 10,795·Total market cap: $144.5T
Actinium Pharmaceuticals, Inc.

Actinium Pharmaceuticals, Inc.

ATNMAMEXHealthcare● Active
$1.06
$-0.02(-1.85%)
Market Cap$33257494
P/E Ratio
52W High$1.945
52W Low$0.952
Overview

Actinium Pharmaceuticals, Inc.(ATNM)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ATNM · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.09M$0.00M$0.08M$1.03M$1.14M
Cost of Revenue$0.00M$0.81M$0.00M$0.00M$0.52M
Gross Profit$0.09M($0.81M)$0.08M$1.03M$0.62M
Gross Margin %(computed)100.00%100.00%100.00%54.20%
Operating Expenses
R&D Expenses$21.12M$30.05M$38.67M$23.14M$17.51M
G&A Expenses$15.21M$12.08M$13.33M$12.00M$0.00M
Total Operating Expenses$36.34M$41.31M$52.00M$35.13M$25.58M
Operating Income($36.25M)($42.12M)($51.92M)($34.10M)($24.96M)
Operating Margin %(computed)
Interest Income$2.36M$3.88M$3.10M$1.09M$0.19M
Interest Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Income Before Tax($33.89M)($38.24M)($48.82M)($33.02M)($24.77M)
Income Tax Expense$0.00M$0.00M$0.00M$0.00M$0.00M
Net Income($33.89M)($38.24M)($48.82M)($33.02M)($24.77M)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.09$-1.27$-1.83$-1.37$-1.20
Wtd Avg Shares31.20M30.07M26.60M24.14M20.57M
EBITDA($35.43M)($37.43M)($51.13M)($33.41M)($24.25M)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M

深入了解Actinium Pharmaceuticals, Inc.

关于Actinium Pharmaceuticals, Inc.(ATNM)损益表

Actinium Pharmaceuticals, Inc.(ATNM)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ATNM实现营收$0.00B,毛利润$0.00B(毛利率100.00%),净利润($0.03B)(净利率-37652.22%)。

常见问题

ATNM · 4 问

Actinium Pharmaceuticals, Inc.(ATNM)2025财年营收为$0.00B,同比up—%。

ATNM revenueATNM salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09